Characteristics of premarketing trials of antipsychotics according to FDA.

Drug brand name shown in parentheses. A dash indicates that the baseline score is not available in the FDA review. For aripiprazole Trial 94202, the number of sites is based on FDA analysis, which excluded site #003 (see text). For the first three iloperidone trials, parentheses enclose the sample size of the subset of patients with schizophrenia analyzed by the FDA. Dose groups shown only if within FDA-approved dose range. For paliperidone Trials 304 and 305, the FDA review did not list results for the olanzapine group: the corresponding n was taken from the corresponding journal article.BPRSd, BPRS score derived from PANSS score; Eur, Europe; Isr, Israel; Mex, Mexico; No Am, North America; Pbo, placebo; So Afr, South Africa; Scz, schizophrenia; Scz-Aff, schizoaffective disorder.